Syntax Bio expands Series A to $14.4M, inks Mayo Clinic collaboration

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.

Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...

Syntax Bio expands Series A to $14.4M, adds leadership and board members

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.
Business Wire

WEBs and Syntax Data Partner to Launch New Defined Volatility Indexes

PARK CITY, Utah--(BUSINESS WIRE)--WEBs, an innovator in volatility-managed investment strategies, and Syntax Data, a financial data and technology company that codifies business models into a ...
Rutland Herald

Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. Collaborate to Evaluate Stem Cell Culture Technologies Using Cellgorithm™ Platform

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...
Los Angeles Times

English Syntax Explained

If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...
Business Wire

Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...